arrow
B

Bruce Campbell

University of Melbourne
H指数:99
被引数:5.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Practical guidance for Win Statistics and Tournament Methods for multifaceted outcomes in stroke research: Review and recommendations

针对卒中研究中多维度结局的Win Statistics和锦标赛方法的实用指南:综述和建议

2026-07-270
OAAI
Infarct growth rate and tenecteplase benefit in ischemic stroke at 4.5 to 24 h without thrombectomy—A secondary analysis of the TRACE-III randomized trial

梗死生长速率及替奈普酶在4.5至24小时内不进行机械取栓的缺血性卒中中的获益—TRACE-III随机试验的二次分析

2026-04-070
PRE
Safety and tolerability of Rinvecalinase Alfa (DM199) for acute ischemic stroke (ReMEDy1)

Rinvecalinase Alfa(DM199)治疗急性缺血性卒中的安全性与耐受性(ReMEDy1)

2025-11-060
OA
Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trial

卒中后综合上肢与语言障碍及功能训练(UPLIFT):一项伞式贝叶斯最优IIa期临床试验的研究方案

2025-09-250
PRE
Intravenous Glyburide in Medical and Endovascular-Treated Large-Core Stroke: A Subgroup Analysis of the CHARM Randomized Clinical Trial

静脉格列本脲在医疗和血管内治疗的大梗死核心卒中中的疗效:CHARM随机临床试验的亚组分析

2025-06-060
PRE
Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天时改良Rankin量表与24小时时美国国立卫生研究院卒中量表作为急性卒中试验的主要结局

2025-02-190
OAAI
Methylprednisolone as Adjunct to Thrombectomy for Acute Intracranial Internal Carotid Artery Occlusion Stroke: Post Hoc Secondary Analysis of the MARVEL Randomized Clinical Trial

甲泼尼龙作为血栓切除术的辅助治疗用于急性颅内颈内动脉闭塞卒中:MARVEL随机临床试验的事后二次分析

2025-02-180
OA
Global challenges in the access of endovascular treatment for acute ischemic stroke (global MT access)

急性缺血性卒中血管内治疗的全球挑战 (Global MT access)

2025-02-030
PRE
Glyburide for Large Hemispheric Infarcts ≤125 mL: a Meta-Analysis of Individual Patient Data from the GAMES-RP and CHARM Trials

格列本脲治疗大半球梗死≤125 mL:一项基于GAMES-RP和CHARM试验个体患者数据的Meta分析

STROKE
IF8.9
2025-02-010
PRE
Modified Rankin Score at 90 Days vs. NIH Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials

90天改良Rankin评分与24小时NIH卒中量表作为急性卒中试验的主要结局指标

STROKE
IF8.9
2025-02-010
PRE
Factors Influencing Nerinetide Effect on Clinical Outcome in Patients Without Alteplase Treatment in the ESCAPE-NA1 Trial

影响ESCAPE-NA1试验中未接受阿替普酶治疗患者神经调节蛋白1疗效的临床因素

stroke
IF8.6
2025-01-310
OA
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke The PUMICE Randomized Clinical Trial

普罗尿激酶与标准治疗用于轻症缺血性卒中患者的PUMICE随机临床试验

2025-01-212
PRE